USE OF NEMONOXACIN FOR TREATING ANTIBIOTIC-RESISTANT STAPHYLOCOCCUS AUREUS INFECTION

摘要

Disclosed is the use of nemonoxacin (formula I) and its enantiomers for treating infections caused by antibiotic-resistant Staphylococcus aureus, particularly, community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). Nemonoxacin is 7-[3-amino-5-methyl-1-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid.